~~<i id='25385CD571'><strike id='25385CD571'><tt id='25385CD571'><pre id='25385CD571'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

Wikipedia

author：Wikipedia 2025-09-28 21:58:02 - browse：58452

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Federal weight loss drug coverage is 30 years out of date

knowledge

Wikipedia

leisure time

Wikipedia

focus

AlastairGrant/APLONDON—AstraZenecasaidTuesdayitwouldacquireFusionPharmaceuticalsinadealworthmorethan

WSS

SCOTUS questions limit to govt efforts to fight misinformation

J&J to buy cancer drug developer Ambrx Biopharma

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

AdventHealth escalates lawsuit against insurance vendor Multiplan

Burning questions for the 2024 JPM Healthcare Conference

Antibiotic resistance and the global rise in human conflict

hotspot

Wikipedia

knowledge

Cancer drug shortages should be causing more outrage

U.K. sequencing study surfaces new findings about tumor DNA

In age of alternative facts, a scholarly course on calling out crap

Methadone treatment changes are coming. Do they go far enough?

The high cost of giving birth even with insurance

Federal weight loss drug coverage is 30 years out of date

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

JPM: CVS says Medicare Advantage patients are impacting profits

At least 13 dead in Texas as scorching temps continue

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Wikipedia

U.K. sequencing study surfaces new findings about tumor DNA

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

Orchard's therapy for neuron disease in children wins FDA approval

JPM: CVS says Medicare Advantage patients are impacting profits

leisure time

leisure time

Wikipedia

focus